Drug maker Pfizer announced today its new antiviral pill has been found to reduce the risk of hospitalization or death from COVID-19 by 89 percent. https://twitter.com/nytimes/status/1456574410618556417 Pfizer’s pill is the second oral treatment for COVID-19 following a similar announcement from Merck, whose antiviral drug has already been approved for use in the UK. From the New York Times:
Pfizer’s pill, which will be sold under the brand name Paxlovid, cut the risk of hospitalization or death by 89 percent when given within three days of the start of symptoms.
Pfizer said an independent board of experts monitoring its clinical trial had recommended that the study be stopped early because the drug’s benefit to patients had proved so convincing.
The company said that it planned to submit the data as soon as possible to the Food and Drug Administration to seek authorization for the pill to be used in the United States.
Read more at the New York Times. The new treatment most probably won’t be available for a few months. https://twitter.com/therecount/status/1456687293348069384 https://twitter.com/SquawkCNBC/status/1456574531762544640
Discover more from The Randy Report
Subscribe to get the latest posts sent to your email.